Council Members in this Study Group: 1333
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Harold Bays, MDPresident and Medical Director
L-MARC Research Center ![]()
Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...
Cardiologist
NEW YORK UNIVERSITY (INC) ![]()
Daniel Fisher, MD, FACC, FACP, is a Cardiologist at NYU Medical Center. He has a private practice in Cardiology and specializes in non-invasive cardiology. Dr. Fisher is board certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. He has lectured frequently on such topicsas...
Clinical Director
NEW YORK UNIVERSITY (INC) ![]()
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...
Clinical Professor of Medicine
UNIVERSITY OF CALIFORNIA, LOS ANGELES ![]()
Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...
Carlos Dujovne, MDProfessor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC ![]()
Carlos Dujovne is the Professor of Medicine, the Chairman of Kansas Foundation for Clinical Pharmacology and Therapeutics (KFCPT), Cardiovascular Division and the Director of Clinical Cardiovascular and Metabolic Risk Treatment Programs at Oregon Health and Science University, in Portland, since July...
Owner
JOSHUA M FEUER ![]()
Joshua Feuer, MD, FACC, is a board certified Cardiologist in solo private practice in Santa Barbara, California. He also serves as a Consulting Cardiologist at Santa Barbara Cottage Hospital. Dr. Feuer specializes in aggressive preventive cardiology and cardiovascular risk assessment and reduction....
Charles Glueck, MDMedical Research Director of Cholesterol Center
Jewish Hospital ![]()
Charles Glueck, MD, is the Medical Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, interaction of atherosclerosis and thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology, and hematology. Dr Glueck and colleagues...
Bernard Chaitman, MDProfessor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE ![]()
Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Ghana Targets Health Tourism Boom: More Evidence of Globalization
October 31, 2009
Ghana targets health tourism boom | news.bbc.co.uk
Just as high tech products are manufactured in Asian countries for a fraction of the cost, medical procedures will be provided in less developed countries for a fraction of the cost in the not so distant future.It will initially be low tech procedures such as cosmetic operations and minor procedures...
We need to learn more about ProSavin Phase I/II Trial in Parkinson’s disease
October 20, 2009
Oxford BioMedica Announces Update on ProSavin® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results | www.pipelinereview.com
This is very interesting news. However, in my judgment it is too early to make a final conclusion concerning this clinical trial. Because it should be taken into account that the growing body of evidence clearly indicates that oxidative stress induced mitochondrial failure appeared to be one of the...
Amyloid Beta does not correlate to Alzheimer Disease.
October 12, 2009
Bayer Schering ties-up with AC Immune for trial in Alzheimer´s disease | www.pharmabiz.com
The finding of amyloid-beta (Aβ) deposition in AD brains after death led to the so-called “amyloid hypothesis”. We have extensively reviewed the literature which claims that AD is caused by the deposition of Aβ within structures called senile plaques that invade AD brains and that such plaque formation...
September 30, 2009
Ronald Innerfield, MD, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.
Controls to blood sugar 'cuts stroke risk' | www.barchester.com
There have been many epidemiologic studies showing a very tight correlation between baseline A1c and cardiovascular mortalityDespite this, five major randomized prospective studies have failed to show any macrovascular benefit for tighter glucose controlThe logical conclusion is that glucose is, therefore,...
The Logical Next Step for Abbott
September 15, 2009
Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology | www.medicalnewstoday.com
With this acquisition Abbott establishes its position as a major player in the field of interventional cardiology and treatment of structural heart disease.The field of structural heart disease therapy is the fastest growing area of interventional cardiology and Abbott is getting in at the ground floor.In...
Leading Experts in General Cardiologists (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in General Cardiologists (US) have not participated in any GLG webcasts.